Tirdzniecība PetIQ, Inc. - PETQ CFD
Pievienot izlasei- Kopsavilkums
- Vēsturiskie Dati
- Notikumi
- Peļņas Atskaite
- Bilance
- Naudas Plūsma
- Īpašums
Starpība | 0.12 | ||||||||
Garās pozīcijas nodeva naktij
Long position overnight fee
Doties uz platformu | -0.025457% | ||||||||
Īsās pozīcijas nodeva naktij
Short position overnight fee
Doties uz platformu | 0.003235% | ||||||||
Nakts laika nodeva | 21:00 (UTC) | ||||||||
Min. tirgotais daudzums | 1 | ||||||||
Valūta | USD | ||||||||
Drošības rezerve | 20% | ||||||||
Fondu birža | United States of America | ||||||||
Tirdzniecības komisija | 0% |
*Information provided by Capital.com
PetIQ Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Iepriekš. aizvērt* | 12.48 |
Atvērt* | 12.25 |
Izmaiņas par 1 gadu* | -23.1% |
Dienas Diapazons* | 12.25 - 12.64 |
52 ned Diapazons | 6.66-18.42 |
Vidējais apjoms (10 dienas) | 177.75K |
Vidējais apjoms (3 mēneši) | 5.56M |
Tirgus Kapitalizācija | 370.51M |
Cenas/Peļņas Attiecība | -100.00K |
Izvietotās Akcijas | 29.38M |
Ieņēmumi | 936.29M |
EPS | -1.44 |
Dividende (Ienesīgums %) | N/A |
Beta | 1.96 |
Nākamās Peļņas Datums | Aug 7, 2023 |
"Visus datus nodrošina Refinitiv, izņemot datus, kas atzīmēti ar zvaigznīti, kas ir *dati, kurus nodrošina Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Aizvēršana | Change | Change (%) | Atvēršana | High | Low |
---|---|---|---|---|---|---|
May 26, 2023 | 12.51 | 0.28 | 2.29% | 12.23 | 12.65 | 12.15 |
May 25, 2023 | 12.48 | -0.25 | -1.96% | 12.73 | 13.04 | 12.21 |
May 24, 2023 | 13.17 | 0.14 | 1.07% | 13.03 | 13.42 | 12.75 |
May 23, 2023 | 13.42 | 0.23 | 1.74% | 13.19 | 13.62 | 12.84 |
May 22, 2023 | 13.31 | 0.15 | 1.14% | 13.16 | 13.49 | 13.03 |
May 19, 2023 | 13.37 | 0.58 | 4.53% | 12.79 | 13.49 | 12.71 |
May 18, 2023 | 12.75 | 0.64 | 5.28% | 12.11 | 12.82 | 11.98 |
May 17, 2023 | 12.60 | 0.45 | 3.70% | 12.15 | 12.70 | 11.96 |
May 16, 2023 | 12.25 | -0.14 | -1.13% | 12.39 | 12.48 | 11.98 |
May 15, 2023 | 12.50 | -0.19 | -1.50% | 12.69 | 12.90 | 12.10 |
May 12, 2023 | 12.68 | -0.45 | -3.43% | 13.13 | 13.13 | 12.62 |
May 11, 2023 | 13.03 | -0.35 | -2.62% | 13.38 | 13.38 | 12.85 |
May 10, 2023 | 13.37 | 1.15 | 9.41% | 12.22 | 14.01 | 11.84 |
May 9, 2023 | 11.49 | 0.14 | 1.23% | 11.35 | 11.59 | 10.92 |
May 8, 2023 | 11.70 | 0.21 | 1.83% | 11.49 | 11.81 | 11.12 |
May 5, 2023 | 11.81 | 0.58 | 5.16% | 11.23 | 11.86 | 11.23 |
May 4, 2023 | 11.37 | 0.11 | 0.98% | 11.26 | 11.44 | 11.14 |
May 3, 2023 | 11.48 | -0.09 | -0.78% | 11.57 | 11.83 | 11.28 |
May 2, 2023 | 11.52 | 0.03 | 0.26% | 11.49 | 11.82 | 11.04 |
May 1, 2023 | 11.73 | 0.33 | 2.89% | 11.40 | 11.97 | 11.37 |
PetIQ, Inc. Events
Laiks (UTC) (UTC) | Valsts | Notikums |
---|---|---|
Wednesday, June 21, 2023 | ||
Laiks (UTC) (UTC) 15:00 | Valsts US
| Notikums PetIQ Inc Annual Shareholders Meeting PetIQ Inc Annual Shareholders MeetingForecast -Previous - |
Thursday, June 22, 2023 | ||
Laiks (UTC) (UTC) 15:00 | Valsts US
| Notikums PetIQ Inc Annual Shareholders Meeting PetIQ Inc Annual Shareholders MeetingForecast -Previous - |
Monday, August 7, 2023 | ||
Laiks (UTC) (UTC) 10:59 | Valsts US
| Notikums Q2 2023 PetIQ Inc Earnings Release Q2 2023 PetIQ Inc Earnings ReleaseForecast -Previous - |
Tuesday, November 7, 2023 | ||
Laiks (UTC) (UTC) 10:59 | Valsts US
| Notikums Q3 2023 PetIQ Inc Earnings Release Q3 2023 PetIQ Inc Earnings ReleaseForecast -Previous - |
- Ikgadējs
- Ceturkšņa
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kopējie ienākumi | 921.513 | 932.528 | 780.051 | 709.431 | 528.614 |
Ienākumi | 921.513 | 932.528 | 780.051 | 709.431 | 528.614 |
Cost of Revenue, Total | 711.85 | 746.135 | 644.863 | 602.048 | 445.326 |
Bruto Peļņa | 209.663 | 186.393 | 135.188 | 107.383 | 83.288 |
Kopējie Darbības Izdevumi | 941.675 | 922.109 | 783.238 | 712.568 | 520.866 |
Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 176.599 | 158.416 | 136.069 | 101.9 | 72.057 |
Pētniecība un Attīstība | 2.1 | 8 | 1.3 | 1.3 | 0.203 |
Neparedzēti Izdevumi (Ienākumi) | 51.126 | 9.558 | 1.006 | ||
Darbības Izdevumi | -20.162 | 10.419 | -3.187 | -3.137 | 7.748 |
Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -27.374 | -24.855 | -22.698 | -14.646 | -7.977 |
Citi, Neto | 0.13 | 1.922 | 0.571 | 0.172 | -0.345 |
Neto Ienākumi Pirms Nodokļu Nomaksas | -47.406 | -12.514 | -25.314 | -17.611 | -0.574 |
Neto Ienākumi Pēc Nodokļu Nomaksas | -48.62 | -16.383 | -85.727 | -14.302 | 0.087 |
Mazākuma Interese | 0.412 | 0.416 | 3.072 | 2.849 | -0.869 |
Neto Ienākumi Pirms Ārkārtas Posteņiem | -48.208 | -15.967 | -82.655 | -11.453 | -0.782 |
Neto Ienākumi | -48.208 | -15.967 | -82.655 | -11.453 | -0.782 |
Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | -48.208 | -15.967 | -82.655 | -11.453 | -0.782 |
Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | -48.208 | -15.967 | -82.655 | -11.453 | -0.782 |
Atšķaidīšanas Iestāstīšana | |||||
Atšķaidītie Neto Ienākumi | -48.208 | -15.967 | -82.655 | -11.453 | -0.782 |
Atšķaidītie Ienākumi par Akcijām | 29.159 | 28.242 | 24.629 | 22.652 | 17.216 |
Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | -1.65328 | -0.56536 | -3.356 | -0.50561 | -0.04542 |
Dividends per Share - Common Stock Primary Issue | |||||
Atšķaidītā Normalizētā Peļņa par Akciju | -0.45486 | -0.19836 | -2.83139 | -0.18333 | -0.04542 |
Ārkārtas Posteņi Kopā | |||||
Other Operating Expenses, Total | 0 | 0 | 7.32 | 3.28 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Kopējie ienākumi | 290.471 | 184.079 | 209.725 | 252.014 | 275.695 |
Ienākumi | 290.471 | 184.079 | 209.725 | 252.014 | 275.695 |
Cost of Revenue, Total | 228.21 | 144.795 | 158.955 | 190.04 | 218.06 |
Bruto Peļņa | 62.261 | 39.284 | 50.77 | 61.974 | 57.635 |
Kopējie Darbības Izdevumi | 271.536 | 182.541 | 252.203 | 240.635 | 266.296 |
Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 43.326 | 37.686 | 45.984 | 49.454 | 45.575 |
Pētniecība un Attīstība | |||||
Neparedzēti Izdevumi (Ienākumi) | 0.06 | 47.264 | 1.141 | 2.661 | |
Darbības Izdevumi | 18.935 | 1.538 | -42.478 | 11.379 | 9.399 |
Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -8.732 | -7.678 | -7.276 | -6.299 | -6.121 |
Citi, Neto | 0.026 | 0.099 | -0.172 | 0.201 | 0.003 |
Neto Ienākumi Pirms Nodokļu Nomaksas | 10.229 | -6.041 | -49.926 | 5.281 | 3.281 |
Neto Ienākumi Pēc Nodokļu Nomaksas | 9.781 | -6.887 | -49.571 | 4.678 | 3.16 |
Mazākuma Interese | -0.082 | 0.052 | 0.435 | -0.046 | -0.029 |
Neto Ienākumi Pirms Ārkārtas Posteņiem | 9.699 | -6.835 | -49.136 | 4.632 | 3.131 |
Neto Ienākumi | 9.699 | -6.835 | -49.136 | 4.632 | 3.131 |
Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | 9.699 | -6.835 | -49.136 | 4.632 | 3.131 |
Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | 9.699 | -6.835 | -49.136 | 4.632 | 3.131 |
Atšķaidītie Neto Ienākumi | 11.375 | -6.835 | -49.136 | 4.632 | 3.131 |
Atšķaidītie Ienākumi par Akcijām | 35.23 | 28.964 | 29.224 | 29.329 | 29.29 |
Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | 0.32288 | -0.23598 | -1.68136 | 0.15793 | 0.1069 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Atšķaidītā Normalizētā Peļņa par Akciju | 0.33477 | -0.22339 | -0.60264 | 0.20931 | 0.20554 |
Other Operating Expenses, Total | |||||
Atšķaidīšanas Iestāstīšana | 1.676 |
- Ikgadējs
- Ceturkšņa
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Apgrozāmo Līdzekļu Kopsumma | 370.112 | 298.689 | 242.296 | 185.423 | 207.721 |
Nauda un Īstermiņa Ieguldījumi | 101.265 | 79.406 | 33.456 | 27.272 | 66.36 |
Nauda un Ekvivalenti | 101.265 | 79.406 | 33.456 | 27.272 | 66.36 |
Debitoru Parādu Kopsumma, Neto | 118.004 | 113.947 | 102.755 | 71.377 | 45.007 |
Accounts Receivable - Trade, Net | 118.004 | 113.947 | 102.755 | 71.377 | 45.079 |
Total Inventory | 142.605 | 96.44 | 97.773 | 79.703 | 92.142 |
Prepaid Expenses | |||||
Other Current Assets, Total | 8.238 | 8.896 | 8.312 | 7.071 | 4.212 |
Total Assets | 818.896 | 819.587 | 771.592 | 672.728 | 495.434 |
Property/Plant/Equipment, Total - Net | 91.626 | 97.102 | 83.268 | 73.31 | 27.335 |
Property/Plant/Equipment, Total - Gross | 140.79 | 137.191 | 114.376 | 93.352 | 40.449 |
Accumulated Depreciation, Total | -49.164 | -40.089 | -31.108 | -20.042 | -13.114 |
Goodwill, Net | 183.306 | 231.11 | 231.158 | 231.045 | 125.029 |
Intangibles, Net | 172.479 | 190.662 | 213 | 119.956 | 88.546 |
Other Long Term Assets, Total | 1.373 | 2.024 | 1.87 | 62.994 | 46.803 |
Total Current Liabilities | 149.49 | 98.102 | 101.067 | 73.014 | 64.196 |
Accounts Payable | 112.995 | 55.057 | 68.131 | 51.538 | 54.768 |
Accrued Expenses | 27.744 | 34.695 | 25.173 | 17.655 | 7.177 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 8.751 | 8.35 | 7.763 | 3.821 | 2.251 |
Total Liabilities | 608.972 | 566.761 | 551.165 | 389.614 | 238.953 |
Total Long Term Debt | 444.183 | 450.963 | 406.929 | 254.707 | 109.737 |
Long Term Debt | 443.276 | 448.47 | 403.591 | 251.376 | 107.418 |
Capital Lease Obligations | 0.907 | 2.493 | 3.338 | 3.331 | 2.319 |
Deferred Income Tax | |||||
Minority Interest | 1.869 | 2.394 | 25.983 | 45.196 | 64.496 |
Other Liabilities, Total | 13.43 | 15.302 | 17.186 | 16.697 | 0.524 |
Total Equity | 209.924 | 252.826 | 220.427 | 283.114 | 256.481 |
Other Equity, Total | -2.224 | -0.684 | -0.686 | -1.131 | -1.317 |
Total Liabilities & Shareholders’ Equity | 818.896 | 819.587 | 771.592 | 672.728 | 495.434 |
Total Common Shares Outstanding | 29.227 | 29.411 | 28.811 | 28.306 | 28.1667 |
Other Current Liabilities, Total | |||||
Common Stock | 0.029 | 0.029 | 0.029 | 0.028 | 0.029 |
Additional Paid-In Capital | 378.709 | 368.006 | 319.642 | 300.12 | 262.219 |
Retained Earnings (Accumulated Deficit) | -162.733 | -114.525 | -98.558 | -15.903 | -4.45 |
Treasury Stock - Common | -3.857 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Apgrozāmo Līdzekļu Kopsumma | 397.152 | 370.112 | 336.183 | 343.627 | 408.024 |
Nauda un Īstermiņa Ieguldījumi | 25.41 | 101.265 | 56.718 | 5.396 | 51.104 |
Nauda un Ekvivalenti | 25.41 | 101.265 | 56.718 | 5.396 | 51.104 |
Debitoru Parādu Kopsumma, Neto | 203.325 | 118.004 | 125.024 | 168.831 | 179.058 |
Accounts Receivable - Trade, Net | 203.325 | 118.004 | 125.024 | 168.831 | 179.058 |
Total Inventory | 158.087 | 142.605 | 147.049 | 160.064 | 167.714 |
Other Current Assets, Total | 10.33 | 8.238 | 7.392 | 9.336 | 10.148 |
Total Assets | 867.715 | 818.896 | 791.714 | 855.035 | 924.434 |
Property/Plant/Equipment, Total - Net | 88.318 | 91.626 | 94.217 | 97.365 | 97.356 |
Property/Plant/Equipment, Total - Gross | |||||
Accumulated Depreciation, Total | |||||
Goodwill, Net | 203.573 | 183.306 | 182.949 | 230.594 | 230.973 |
Intangibles, Net | 176.145 | 172.479 | 176.936 | 181.566 | 186.111 |
Other Long Term Assets, Total | 2.527 | 1.373 | 1.429 | 1.883 | 1.97 |
Total Current Liabilities | 186.187 | 149.49 | 115.907 | 119.17 | 173.415 |
Accounts Payable | 150.012 | 112.995 | 73.399 | 81.093 | 128.913 |
Accrued Expenses | 27.5 | 27.744 | 34.017 | 29.63 | 36.091 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 8.675 | 8.751 | 8.491 | 8.446 | 8.411 |
Total Liabilities | 646.423 | 608.972 | 578.301 | 589.914 | 665.537 |
Total Long Term Debt | 442.641 | 444.183 | 446.079 | 452.734 | 475.109 |
Long Term Debt | 441.938 | 443.276 | 444.598 | 450.904 | 472.945 |
Capital Lease Obligations | 0.703 | 0.907 | 1.481 | 1.83 | 2.164 |
Minority Interest | 1.857 | 1.869 | 1.899 | 2.32 | 2.262 |
Other Liabilities, Total | 15.738 | 13.43 | 14.416 | 15.69 | 14.751 |
Total Equity | 221.292 | 209.924 | 213.413 | 265.121 | 258.897 |
Common Stock | 0.029 | 0.029 | 0.029 | 0.029 | 0.029 |
Additional Paid-In Capital | 380.429 | 378.709 | 376.277 | 374.057 | 371.398 |
Retained Earnings (Accumulated Deficit) | -153.034 | -162.733 | -155.898 | -106.762 | -111.394 |
Other Equity, Total | -2.275 | -2.224 | -3.138 | -2.203 | -1.136 |
Total Liabilities & Shareholders’ Equity | 867.715 | 818.896 | 791.714 | 855.035 | 924.434 |
Total Common Shares Outstanding | 29.37 | 29.227 | 29.198 | 29.556 | 29.524 |
Other Current Liabilities, Total | 0.001 | ||||
Treasury Stock - Common | -3.857 | -3.857 | -3.857 |
- Ikgadējs
- Ceturkšņa
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Neto ienākumi/Sākuma Līnija | -48.62 | -16.383 | -81.022 | -14.302 | 0.087 |
Nauda no Darbības | 48.024 | 23.767 | -4.601 | 20.833 | -12.413 |
Nauda no Darbības | 35.468 | 39.3 | 30.975 | 16.509 | 12.467 |
Bezskaidras Naudas Preces | 58.68 | 13.931 | 16.897 | 14.891 | 6.684 |
Samaksātie Procenti Naudā | 26.404 | 19.189 | 19.402 | 13.632 | 7.22 |
Izmaiņas Apgrozāmajā Kapitālā | 1.897 | -16.568 | -22.962 | 7.193 | -30.808 |
Nauda no Ieguldījumu Darbībām | -11.973 | -26.138 | -118.022 | -195.026 | -100.001 |
Kapitālie Izdevumi | -11.973 | -31.27 | -118.464 | -10.276 | -7.178 |
Citi Ieguldījumu Naudas Plūsmas Posteņi, Kopā | 0 | 5.132 | 0.442 | -184.75 | -92.823 |
Nauda no Darbībām ar Finansēšanu | -13.71 | 48.334 | 128.764 | 135.059 | 140.97 |
Naudas Plūsma Finansēšanas Posteņos | -0.875 | -8.663 | -7.076 | -7.59 | -4.235 |
Parādu Izsniegšana (Atkāpšanās), Neto | -9.093 | 43.571 | 141.387 | 140.331 | 69.862 |
Ārvalstu Valūtas Ietekme | -0.482 | -0.013 | 0.043 | 0.046 | -0.092 |
Neto Izmaiņas Naudā | 21.859 | 45.95 | 6.184 | -39.088 | 28.464 |
Deferred Taxes | 0.599 | 3.487 | 51.511 | -3.458 | -0.843 |
Cash Taxes Paid | 0.359 | 0.418 | 0.13 | 0.249 | 0.64 |
Akciju Izsniegšana (Atkāpšanās), Neto | -3.742 | 13.426 | -5.547 | 2.318 | 75.343 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 9.781 | -48.62 | -41.733 | 7.838 | 3.16 |
Cash From Operating Activities | -43.327 | 48.024 | -0.872 | -65.384 | -45.38 |
Cash From Operating Activities | 8.463 | 35.468 | 26.564 | 17.66 | 8.966 |
Non-Cash Items | 2.414 | 58.68 | 56.217 | 6.714 | 4.287 |
Cash Taxes Paid | -0.003 | 0.359 | 0.258 | 0.244 | 0.005 |
Cash Interest Paid | 6.808 | 26.404 | 18.55 | 13.38 | 4.072 |
Changes in Working Capital | -63.985 | 1.897 | -41.92 | -97.596 | -61.793 |
Cash From Investing Activities | -29.544 | -11.973 | -9.797 | -8.026 | -5.678 |
Capital Expenditures | -1.91 | -11.973 | -9.797 | -8.026 | -5.678 |
Cash From Financing Activities | -3.086 | -13.71 | -11.401 | -0.294 | 22.863 |
Financing Cash Flow Items | -0.84 | -0.875 | -0.862 | -0.865 | -0.688 |
Issuance (Retirement) of Stock, Net | 0 | -3.742 | -3.742 | 0.115 | 0.1 |
Issuance (Retirement) of Debt, Net | -2.246 | -9.093 | -6.797 | 0.456 | 23.451 |
Foreign Exchange Effects | 0.102 | -0.482 | -0.618 | -0.306 | -0.107 |
Net Change in Cash | -75.855 | 21.859 | -22.688 | -74.01 | -28.302 |
Deferred Taxes | 0.599 | ||||
Other Investing Cash Flow Items, Total | -27.634 | 0 | 0 | 0 |
Investora vārds | Investora veids | Nenokārtots procents | Akcijas turējumā | Izmaiņas akcijās | Turēšanas termiņš | Apgrozījuma reitings |
---|---|---|---|---|---|---|
Eos Management, L.P. | Hedge Fund | 6.7702 | 1972687 | 0 | 2023-03-31 | LOW |
Clarke (James Nathan) | Individual Investor | 5.8028 | 1690802 | 1690802 | 2023-04-24 | |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 5.743 | 1673378 | 83281 | 2023-03-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.5649 | 1621477 | 15776 | 2023-03-31 | LOW |
Applied Fundamental Research, LLC | Investment Advisor | 5.4379 | 1584479 | -49383 | 2023-03-31 | |
Aristotle Capital Boston, LLC | Investment Advisor | 4.3057 | 1254589 | 79121 | 2023-03-31 | LOW |
Boston Partners | Investment Advisor/Hedge Fund | 3.8618 | 1125246 | -430482 | 2023-03-31 | LOW |
Nepsis, Inc. | Investment Advisor | 3.2807 | 955925 | 70728 | 2023-03-31 | MED |
Brandywine Global Investment Management, LLC | Investment Advisor | 2.526 | 736033 | 14816 | 2023-03-31 | LOW |
Goldman Sachs & Company, Inc. | Research Firm | 2.5049 | 729873 | -8469 | 2023-03-31 | MED |
Ensign Peak Advisors, Inc. | Foundation | 2.4014 | 699704 | 35502 | 2023-03-31 | LOW |
Millennium Management LLC | Hedge Fund | 2.1517 | 626968 | -149081 | 2023-03-31 | HIGH |
Thornburg Investment Management, Inc. | Investment Advisor | 2.1429 | 624390 | 0 | 2023-03-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 1.98 | 576939 | 149430 | 2023-03-31 | LOW |
Allianz Global Investors GmbH | Investment Advisor | 1.9308 | 562604 | 6618 | 2023-03-31 | LOW |
Marshall Wace LLP | Investment Advisor/Hedge Fund | 1.8004 | 524592 | 28052 | 2023-03-31 | HIGH |
Minneapolis Portfolio Management Group, L.L.C. | Investment Advisor | 1.7384 | 506544 | -6279 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.7349 | 505503 | 12762 | 2023-03-31 | LOW |
AQR Capital Management, LLC | Investment Advisor/Hedge Fund | 1.6616 | 484154 | 2444 | 2023-03-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 1.637 | 476981 | 8198 | 2023-03-31 | LOW |
Kāpēc izvēlēties Capital.com? Mūsu skaitļi runā paši par sevi.
Capital.com Group530K+
Tirgotāji
87K+
Ikmēneša aktīvie klienti
$46M+
Ikmēneša ieguldījumu apjoms
$31M+
Izņemts katru mēnesi
Treidinga kalkulators
Aprēķiniet iespējamo peļņu un zaudējumus, uzsākot CFD darījumu noteiktā dienā (izvēlaties datumu) un slēdzot darījumu citā dienā (izvēlaties datumu).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
PetIQ, Inc. Company profile
Par PetIQ, Inc.
PetIQ, Inc. ir mājdzīvnieku medikamentu un labsajūtas uzņēmums. Uzņēmums piegādā veterināros produktus un pakalpojumus. Uzņēmums darbojas divos segmentos: Produkti un pakalpojumi. Produktu segmentu veido ražošanas un izplatīšanas uzņēmējdarbība. Pakalpojumu segments ietver veterināros pakalpojumus un saistīto produktu pārdošanu, ko uzņēmums sniedz tieši patērētājiem. Uzņēmums piedāvā savus produktus dažādās kategorijās, tostarp Rx medikamentus, bezrecepšu medikamentus un piederumus, kā arī veselības un labsajūtas produktus. Rx zāles lolojumdzīvniekiem ietver profilaktiskos līdzekļus pret sirdstārpiem, pret artrītu, vairogdziedzeri, diabētu un sāpju ārstēšanu, antibiotikas un citus speciālos medikamentus. Uzņēmums izplata dažādus medikamentus, tostarp Nexgard, Heartgard Plus un Vetmedin. Bezrecepšu medikamenti un piederumi ietver blusu un ērču kontroles produktus. Veselības un labsajūtas produkti ietver īpašus našķus un citus lolojumdzīvnieku produktus, piemēram, zobu kārumus un uztura bagātinātājus.
Industry: | Veterinary Drugs |
Petiq Llc
230 E. Riverside Dr.
EAGLE
IDAHO 83616
US
Peļņas Atskaite
- Annual
- Quarterly
Cilvēki arī skatās
Vai joprojām meklējat mākleri, kuram varat uzticēties?
Pievienojieties 530 000+ tirgotājiem visā pasaulē, kuri izvēlējās tirgoties ar Capital.com